Hot Supermarket Stocks To Watch For 2015

Hot Supermarket Stocks To Watch For 2015: XOMA Ltd.(XOMA)

XOMA Ltd., a biopharmaceutical company, engages in the discovery, development, and manufacture of therapeutic antibodies to treat autoimmune, infectious, inflammatory, and oncological diseases. Its products under development include gevokizumab, an anti-inflammatory monoclonal antibody that inhibits interleukin-1 beta and has completed Phase 2 development stage for the treatment of Behcet?s uveitis, as well as is in Phase 2b clinical trail for Type 2 diabetes with cardiovascular biomarkers; XOMA 3AB, a biodefense anti-botulism product candidate comprising a combination or cocktail of antibodies for the treatment of botulism poisoning; and preclinical antibody discovery programs in various indications, including autoimmune, cardio-metabolic, inflammatory, and oncological diseases. The company, through its collaboration agreement with Novartis AG, is also developing HCD122, a human anti-CD40 antagonist antibody that is in Phase 1/2 clinical trial for the treatment of B-cell mediated diseases, including malignancies and autoimmune diseases; and LFA102, which is in Phase 2 clinical trial for the treatment of hematologic tumors and other undisclosed diseases. In addition, it licenses proprietary technologies relating to bacterial expression of recombinant pharmaceutical products to biotechnology and pharmaceutical companies. The company has collaboration agreements with Les Laboratoires Servier; National Institute of Allergy and Infectious Diseases; SRI International; Takeda Pharmaceutical Company Limited; Novartis AG; Arana Therapeutics Limited; Kaketsuken; Genentech, Inc.; and UCB Celltech. XOMA Ltd. was founded in 1981 and is headquartered in Berkeley, California.

Advisors' Opinion:

• [By Jake L'Ecuyer]

  Equities Trading DOWN
  Shares of XOMA (NASDAQ: XOMA) were down 27.54 percent to $6.84 after the company reported Q4 results and provided anupdate on its gevokizumab development program. Credit S! uisse downgraded the stock from Outperform to Neutral.

• [By Lisa Levin]

  XOMA (NASDAQ: XOMA) shares gained 7.55% to $4.70 in the pre-market session on encouraging Phase 2 Gevokizumab results.

  Central European Media Enterprises (NASDAQ: CETV) soared 5.67% to $2.98 in the pre-market trading. Central European Media shares have tumbled 48.07% over the past 52 weeks, while the S&P 500 index has gained 23.52% in the same period.

• [By John Kell and Lauren Pollock var popups = dojo.query(".socialByline .popC"); ]

  XOMA Corp.(XOMA) said it swung to a loss in the fourth quarter, as an increase in operating expenses offset revenue gains. The drug developer’s losses were wider than expected by the market, sending shares down 20% to $7.54 premarket.

• [By Lisa Levin]

  XOMA (NASDAQ: XOMA) shares reached a new 52-week high of $8.61. XOMA shares have jumped 196.09% over the past 52 weeks, while the S&P 500 index has gained 25.27% in the same period.

source from Top Penny Stocks For 2015:http://www.seekpennystocks.com/hot-supermarket-stocks-to-watch-for-2015-2.html